Packaging Barrier Films Market Expectations and Growth Trends Highlighted Until 2030

Global packaging barrier films market is expected to witness a definitive surge as the demand for safe packaging for food and beverages remains a grave concern. The risk of food spoilage while handling and storing is projected to fuel the uptake of packaging barrier films in the coming years. The impermeable nature of barrier films makes them ideal for storing packaged food.

Over the years, development of sturdy material that keep the contents away from exposure to oxygen and other gases has strengthened the case for these films. Furthermore, packaging barrier films do not react with packaged food, which makes an ideal choice.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-5000

Analysts project that meat and fish will be the growing end use of packaging barrier films are they have the least oxygen transmission rate. The growing consumption of frozen food, lifestyle that dictate easting convenient food, and booming restaurant industry are expected to fuel the growth of this market in the coming years.

According to Future Market Insights, the global packaging barrier films market is expected to register a CAGR of 5.2% during the forecast period of 2020 and 2030.

Global Packaging Films Market Study and Findings

  • Packaging barrier films are highly preferred in the pouches and shrink films packaging. Hence, these application segments are expected to account for around 58% of the collective market share by the end of forecast period.
  • Food and beverages segment to account for significant uptake of packaging barrier films as demand for frozen food reaches all time high
  • Pharmaceutical industry to contribute as hospital admissions remain high throughout the globe
  • Emerging economies of India and China to be key raw material suppliers
  • LDPE to remain highly used material as it offers exceptional barrier to moisture, strength, and flexibility

“Packaging barrier films market is expected to see a remarkable rise in the coming years as food consumption patterns change drastically. With increasing investments in research and development to manufacture stronger films, manufacturers are expected to lure bigger consumer base. In the coming years, manufacturers are expected to focus on building a circular economy by ensuring these films are recycled and reused,” says FMI analyst.

Smaller Packs to Lead Growth for Packaging Barrier Films as Preference Shifts

The demand for packaging barrier films is expected to be driven by small sized packs, which are easily reusable. Growing number of travelers and increasing awareness about reusing plastic-made items have contributed to this demand. Demand for light weight packaging products has also defined the success of packaging barrier films.

Consumers are increasingly opting for peel able packaging solutions. The demand for these will be high in packaging of cheese, meats, and poultry products. Thus, the growing consumption of these products will indirectly affect the sales of packaging barrier films.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-5000

COVID-19 Impact on Packaging Barrier Films

The impact of COVID-19 can be felt on global packaging barrier films as the sales of cosmetics have suffered to a great degree. The market has taken a hit due to ban on international travel and trade. Furthermore, stringent lockdowns that restricted e-commerce industry as well have led to a drop in the sales of packaging barrier films in the first two quarters of 2020.

However, analysts project that the demand for packaging barrier films is expected to regain normalcy as its demand picks up in pharmaceutical and food and beverage industry. As restaurants open for delivery and with limited capacity, they are further expected give the global market an impetus.

Packaging Barrier Films Market Report

Future Market Insights, in its new report, offers an unbiased analysis of the global packaging barrier films market, analyzing historical demand from 2015-2019 and forecast statistics for 2020-2030. The collation shrink films market is segmented into material (PE, BOPET, PP, inorganic oxides, aluminum, polyamide, PVDC, EVOH, and others), product type (metallized films, organic coating films, inorganic oxide coating films, and other barrier films), barrier type (low barrier, medium barrier, high barrier, and ultra-high barrier), application (pouches, blister pack base webs, shrink films, stretch wraps, sachets, and lids) across seven regions.

 

About us :

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact :

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Inflammatory Markers Market By Product, By Technology, By Application, By Region, And Segment Forecast 2022 – 2029

Inflammatory markers are used in the assessment of cancer and other chronic diseases. Inflammation markers raise in the inflammatory conditions. C reactive protein and interleukin are the most common form of inflammatory markers.

Some of the common inflammatory conditions include rheumatoid arthritis, tissue injury and burns, Crohn’s disease, cancer, etc.

Introduction of an infectious organism including mycobacterium tuberculosis, protozoa, fungi, and other parasites that can resist host defenses and remain in the tissue for an extended period, is one of the major cause of chronic inflammation. Other causes of chronic inflammation include exposure to a low level of particular irritant and foreign particles, autoimmune diseases, in which the immune system is sensitized. Chronic inflammation can be caused due to repeated episodes of acute inflammation

Inflammatory markers: Market Dynamics

Increasing prevalence of cancer is one of the major factors, responsible for the significant growth of inflammatory markers market. Increasing population especially in developing regions and increasing prevalence of other chronic diseases, is expected to increase the growth of inflammatory markers market. Increasing research and developmental activities is another important factor which can drive the growth of inflammatory markers market. Other factors such as increasing healthcare awareness, an increasing number of hospitals and research laboratories, etc. are expected to increase the growth of inflammatory markers market. Increasing government initiatives and increasing government funding for the research activities, is a very important factor which can increase the growth of inflammatory markers market. An increasing number of diagnostic laboratories is expected to increase the growth of global inflammation markers market.

There are a few factors, which can restrain the growth of inflammatory markers market. Lack of healthcare awareness in some of the emerging regions is expected to increase the growth of the global inflammatory markers market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-10251

Global Inflammatory markers Market: Overview

Based on product type, inflammatory markers market has been segmented into interlukins, C reactive proteins, lepitine, cellular adhesion molecules, tumor necrosis factors and others. Interlukins are expected to hold a large revenue share in the global inflammatory markers market. Based on the indications, the global inflammatory markers market has been segmented into tumors, arthritis, multiple sclerosis, diabetes and various other applications. Tumors are expected to hold a large revenue share in the overall inflammatory markers market. Based on the end user, the inflammatory markers market has been segmented into hospitals, clinics, research laboratories and others. Research laboratories are expected to hold a significant share in the global inflammatory markers market.

Global Inflammatory markers Market: Region-wise Outlook

On the basis of geography, global inflammatory markers market is segmented into several key regions viz. North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East and Africa. North America is expected to hold the largest shares in the inflammatory markers market primarily due to presence of well-established healthcare infrastructure and the presence of large number of research laboratories Europe is expected to hold a large revenue share in Inflammatory markers market due to increasing population and increasing prevalence of chronic diseases. Asian countries are also expected to hold a significant growth rate in the forecast period due to increasing healthcare awareness among the people.

Inflammatory markers Market: Key Players

There are many companies manufacturing inflammatory markers. Some of the key players present in Global Inflammatory markers market are Merck and Co., Novartis International AG, Abnova, Cayman Chemical, Thermo Fisher Scientific, Cell Signaling Technology, Inc., Boditech Med Inc., LSI Medience Corporation, Abbott Diagnostics Inc., Siemens Healthcare Diagnostics Inc., BG Medicine Inc., LifeSign LLC.

The report covers exhaustive analysis on:

Inflammatory markers Market Segments

Inflammatory markers Market Dynamics

Inflammatory markers Market Size

Current Trends/Issues/Challenges

Competition & Companies involved

Value Chain

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-10251

The regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)

Japan

The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Global Inflammatory Market: Segmentation

 

Global Inflammatory markers is segmented by product type, indication and end user:

Segmentation by Product Type

Interlukin

Interlukin 6

Interlukin 10

Others

C Reactive Protein

Lepitine

Cellular adhesion molecule

Tumor necrosis factor-α

Others

Segmentation by Indications

Tumors

Arthritis

Multiple Sclerosis

Diabetes

Other Applications

Segmentation by End Users

Hospitals

Diagnostic Laboratories

Research Laboratories

Others

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-10251

Zipper Pouch Market Analysis by Size, Share, Growth, Trends up to 2031

Zipper pouches will emerge as top-selling packaging solutions in the packaged food industry in the coming decade. In its latest study Future Market Insights (FMI) predicts sales to expand at a CAGR of 5.3% between 2021 and 2031. The overall valuation of the market is projected to surpass US$ 2.1 Bn by the end of 2021.

Disruptions in the supply chain following the outbreak of the coronavirus and consequent restrictions on movement and transport have negatively impacted sales. However, recovery is likely through 2021 and beyond. Expansion of the packaged food industry and the ever-growing demand for fresh produce will offer ample growth opportunities to manufacturers in upcoming years.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-4773

Zipper pouches are accepted worldwide because they are both re-sealable and re-usable. These products also offer strong barriers to external atmosphere and temperature fluctuations. Applications of zipper pouches in the pharmaceutical, cosmetics, and personal care industries are gaining traction.

Marketers and retailers are able leverage zipper pouches to fulfil demand for packaging aesthetics. Also, consumer convenience through clear packaging attributes is likely to fuel demand for the foreseeable future.

In recent years, manufacturing giants have shifted their focus on the use of recyclable raw materials such as polyethylene (PE), polyvinyl chloride (PVC) and polypropylene (PP). Improvements in machinery have enabled large scale production with minimal waste.

Largely, the zipper pouch market is projected to grow supported by the usage of sustainable materials and green practices by producers and end-use industries.

Key Takeaways from the Zipper Pouch Market Study

  • Stand up zipper pouches account for more than 79% market value, owing to relative ease of use.
  • In North America, the U.S. holds a market share of almost 89% in 2021, driven by a matured packaged food sector.
  • The zipper pouch market in Germany is anticipated to exhibit a growth rate of 5% supported by the large-scale manufacturing sector of the country.
  • India is a fast-growing market in APEJ, driven by a large consumer base and changing consumer food and beverage consumption trends.
  • Zipper pouches are most widely used packaging various types of food products, as it holds almost 76% of market share in the year 2021.

“Expansion of the global zipper pouch market is largely driven by a surge in demand for packaged foods. The need to preserve food items and offer protection against harsh atmospheric conditions have aided developments in the industry. Most manufacturers are focusing eco-friendly raw materials and sustainable practices for producing making zipper pouches” says the FMI analyst.

Shifting Consumer Preference Towards Resealable Packaging Drives Demand

The trend of stand-up pouches is driven by consumer preference for lightweight, portable, and resealable products. Companies are focusing on developing reusable, recyclable, and durable pouches.

These stand-up pouches are specially made with polyethylene terephthalate, polyethylene or Ethylene Vinyl Alcohol (EVOH) with integrated zippers and are also available in partially transparent variables.

The product is lightweight, recyclable and is mainly used for packaging dry and frozen food. This shift in packaging trends is resulting in a surge in adoption of zipper pouches with significant demand arising from household applications.

Zipper Pouch Market by Category

By Product Type:

  • Stand Up Zipper Pouch
  • Flat Zipper Pouch

By Material Type:

  • Plastic
    • Polyethylene (PE)
    • Polypropylene (PP)
    • Polyvinyl Chloride (PVC)
  • Aluminum Laminates
  • Paper
  • Others

By Closure Type:

  • Slider Zip
  • Press to Close

By End Use:

  • Food
    • Fruits & Vegetables
    • Meat, Poultry & Sea Food
    • Bakery & Confectionery
    • Ready-to-eat food
    • Dairy Products
    • Cereals
    • Pet Food
  • Pharmaceuticals
  • Cosmetics & Personal Care

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-4773

Zipper Pouch Market Landscape

Key players contribute 20-30% of the global market. Market leaders are largely engaged in strategies to expand production capacity while investing in material innovations to improve on packaging barrier properties.

Berry Global Group, Amcor plc and Rengo Co. Ltd., Transcontinental Inc., C.I. Takiron Corporation and Novolex Holdings, LLC are some of the leading players in the zipper pouch market

 

About us :

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact :

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Security Bags Market Estimated to Expand at a Robust CAGR By 2031

In a recent market survey, Future Market Insights (FMI) has projected the demand in the security bags market to grow by 8% CAGR between 2021 and 2031. The overall security bags market size is expected to total US$ 419 Mn in 2021. Growing public sector investments in the development of secure packaging solutions are expected to push sales of security bags over the assessment period.

Amid the COVID-19 outbreak, sales of security bags gained traction, exhibiting year-over-year growth at 8.3% between 2020 and 2021. Security bags were widely being adopted for secure handling and transport of novel drugs and vaccines to contain the market, which in turn propelled sales of security bags in the pharmaceutical sector.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-4011

This trend is expected to continue in the forthcoming years, as several countries are still bearing the brunt of the COVID-19 pandemic. Growing demand for security bags for no-contact delivery of pharmaceuticals and other non-essential goods delivered through eCommerce is expected to bode well for the market.

Apart from this, increasing adoption of security bags in financial institutions such as banks and credit unions will continue augmenting growth of the market. Tamper-proof security bags are ideal for transferring and storing cash and coins, as thieves can’t steal the contents without leaving any trace.

Rising demand for sustainable security bags in hotels and casinos is compelling manufacturers to launch new variants of security bags made of recyclable materials. Consumers are increasingly preferring recyclable packaging solutions to reduce their carbon footprint as a part of their social responsibilities. This is expected to create lucrative opportunities for existing players and new entrants in the global security bags market.

“Increasing applications of security bags for safe handling of crime scene evidence in forensics and government organizations, coupled with growing demand for durable packaging in the eCommerce sector, will continue fostering growth of the market through 2031,” says an FMI analyst.

Key Takeaways:

  • Demand for plastic security bags is expected to remain high, owing to durability and optimal protection offered by plastic materials such as PVC and LDPE.
  • In terms of application, the pharmaceutical distribution segment is expected to account for a dominant share of the global security bags market.
  • Based on product type, opaque security bags will remain most preferred, due to their diverse applications in various end-use sectors.
  • Applications of security bags in financial institutions will continue gaining traction, owing to growing preference for reliable and sustainable packaging solutions.
  • The U.S. will continue exhibiting high demand for security bags. Sales of security bags in the North America region are expected to expand at a 7.6% CAGR through 2031.
  • The U.K. will emerge as a lucrative market, with demand for security bags growing at a 7.1% CAGR in the Europe market.
  • China is expected to command lion’s share of the East Asia security bags market over the forecast period.
  • Japan and South Korea will account for 14% and 9% of the East Asia security bags market share in 2021.

Security Bags Market by Category

By Raw Material Type:

  • Plastic
  • Paper
  • Fabric

By Product Type:

  • Opaque
  • Clear

By Application:

  • Cash/Coin Deposit Bags
  • Strap Bags
  • Card & Dice Bags
  • Evidence Bags
  • Pharmaceutical Distribution Bags

By End-Use:

  • Financial Institutions
  • Hospitals
  • Casinos
  • Hotels
  • National Retail Companies

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-4011

Competitive Landscape

Ampac Holdings LLC., Coveris Holdings S.A., Mega Fortris, KOROZO Ambalaj San.ve Tic A.S., and Harwal Ltd. are among the key players operating in the global security bags market. As per FMI, top 5 players in the security bags market are expected to account for 10-15% of the total market share in 2021.

Key players operating in the global security bags market are investing in research and development to improve their product portfolios by offering sustainable security bags. Apart from this, players are also investing in mergers, acquisitions, collaborations to expand their global footprint. For instance:

  • In July 2021, ProAmpac, a global leader in flexible packaging and material sciences, acquired Euroflex, an Ireland-based flexible printing firm that develops films, lamination, tamper-proof security bags, and pouching packaging solutions.
  • In November 2019, Korozo acquired Vitra NV and Creavit NV. Vitra NV is a Belgium-based packaging firm that specializes in thin films packaging, labels, security bags, and small-sized bags for transit and postal services. Creavit NV is an in-house design and pre-press department owned by Vitra.

More Insights into the Security Bags Market Report

In its latest report, FMI offers an unbiased analysis of the global security bags market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of raw material type (plastic, paper, and fabric), product type (opaque and clear), application type (cash/coin deposit bags, strap bags, card & dice bags, evidence bags, and pharmaceutical distribution bags), and end-use (financial institutes, hospitals, casinos, hotels, national retail companies, government organizations, courier service companies, and academic institutions) across seven regions (North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan (APEJ), Japan, and Middle East & Africa).

About us :

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact :

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Next Generation Packaging Market to Garner Brimming Revenues by 2025

Future Market Insights (FMI) delivers key insights on the global next generation packaging market in its upcoming report titled “Next Generation Packaging Market: Global Industry Analysis and Opportunity Assessment 2015-2025”. The global next generation packaging market is projected to expand at a CAGR of 6.01% during the forecast period due to various factors, regarding which FMI offers vital insights in detail in this report.

On the basis of applications, the market has been segmented into food & beverages, healthcare & pharmaceuticals, personal care, logistics & supply chain and others. The food & beverages applications segment is estimated to account for over 43% share of the global next generation packaging market by the end of 2015. The healthcare & pharmaceutical applications segment is expected to be the second largest segment, accounting for over 30% share of global next generation packaging market by the end of 2015. The personal care applications segment is expected to expand rapidly at a CAGR of 6.30% during the forecast period. Furthermore, the logistic & supply chain application segment in the market is expected to cross US$ 4.00 Bn mark by the end of 2025.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-709

On the basis of packaging type, the market has been segmented into various types, such as active packaging, intelligent packaging and modified atmosphere packaging (MAP). Among all the types, the active packaging segment is expected to hold the largest market share of over 36% by the end of 2015, followed by intelligent packaging segment, which is expected to account for over 33% share of the overall market by the end of 2015. The modified atmosphere packaging segment is expected to account for over 29% share of the overall market by the end of 2015, but it is expected to lose its share to other packaging types by the end of 2025.

Growth of the global next generation packaging market is mainly driven by increasing aging population, overall advances in packaging materials and rising need of sustainable packaging. Moreover, trends that are driving the growth of the next generation packaging market are increasing research and development spending on packaging technology, growing adoption of Quick Response (QR) codes on packaging and development of advanced sensors.

Browse Full “Next Generation Packaging Market: Global Industry Analysis and Opportunity Assessment 2015 – 2025” Market Research Report at https://www.futuremarketinsights.com/reports/next-generation-packaging-technology-market

This report covers trends that are driving the growth of each segment and respective sub-segments and offers analysis and insights on the potential of the next generation packaging market in specific regions. North America is expected to dominate the next generation packaging market, accounting for over 36% share of the overall market by the end of 2015, and is anticipated to remain dominant till the end of 2025. Western Europe is expected to be the second largest market, accounting for over 20% of market share by the end of 2015. APEJ and Japan, collectively, are expected to account for over 26% share of the total next generation packaging market by the end of 2015. Among all the regions, Latin America is anticipated to expand at the highest CAGR from 2015 to 2025, followed by the Middle East & Africa, due to increasing investment and economic development in these regions.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-709

Key players in the global next generation packaging market include Amcor Limited, WestRock Company (Formerly MeadWestvaco Corporation), Sonoco Products Company, Sealed Air Corporation, Stora Enso Oyj, Bemis Company, Inc., MULTIVAC, WS Packaging Group, Inc., Active Packaging Ltd. and ULMA Packaging, S.Coop  .Currently, major participants, such as Amcor Limited and Sonoco Products Company, are focusing more on business expansion in emerging regions in order to enhance their global presence. In addition, these key players are also focusing on expanding their packaging portfolio through acquisitions and mergers. For example, in 2015, MeadWestVaco Corporation and Rock-Tenn Co. merged together by creating new WestRpck Company. This Merger will help them to be a second-largest packaging company in the U.S. In 2015, Stora Enso Oyj entered into a joint development agreement with NXP Semiconductors N.V. for developing intelligent packaging solutions. This development is intended to primarily focus on the integration of RFID technology into packaging, in order to enhance consumer engagement and improve supply chain efficiency.

 

About us :

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact :

Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Contraceptive Market Size 2022 Analysis by Top Key Players- ayer AGPfizer Inc., LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V.

The global contraceptives market size is expected to reach ~US$ 33,529 Mn by the end of 2029. According to a study by Future Market Insights (FMI), the market will show a steady rise at a CAGR of ~6.2% between 2019 and 2029. According to the report, growing need of population control, increasing incidence of unwanted pregnancies and government’s initiatives drive the contraceptive market forward. It uses unique research methods to offer the most accurate analysis of the market.

It includes in-depth insights into the contraceptives market. Some of these are:

  • The estimated value of the contraceptives market was at ~US$ 33,529 Mn in 2019. Through the course of the report’s forecast period, the market is exhibited to show a steady pace of growth.
  • Regionally, North America dominates the contraceptives market globally.
  • East Asia emerges as one of key markets owing to large population base, growing contraceptive awareness and initiatives taken by the respective country government.
  • Female segment holds the most of the contraceptive market as compared to men.
  • Key players are likely to focus on new product development in terms of drug & device, to stay relevant in developed markets.

To remain ahead of your competitors, request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-1091

Contraceptive Pills – the Most Lucrative Product Type

Contraceptive market contains drugs and devices. The devices market holds most the contraceptive market however drugs are anticipated to grow at highest CAGR owing to its beneficial property and easy consuming method. With the advancement of technology, the emergence of drugs have become popular as oral contraceptive pills which has the same purpose as other contraceptive drugs or devices. The simplicity and easy consumable method are expected to make it most popular contraceptive market. The other form of drugs such as topical and injectable contraceptives also witness strong market demand. Furthermore, these contraceptive pills are highly effective and does not interrupt in sex. Even in cases, it has been proved to reduce heavy and painful periods. All these factors and benefits are expected to fuel the sales of contraceptive drugs in the global market.

Some of the leading players operating in the contraceptives market are Bayer AGPfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc, Reckitt Benckiser Group plc, Veru Inc., Church & Dwight Co., Inc., Medisafe Distribution Inc., Cooper Surgical, Inc., Mayer Laboratories, Inc., Pfizer, The Female Health Company and others. As a result of increasing competition, companies are focusing on expanding their product portfolio with new innovation. In addition to this, mergers and acquisition remains a popular strategy among market players. Companies intend to expand their regional footprint through strategic collaborations.

  • As a part of government’s initiative, the government of India had launched a new contraceptive pill named ‘Shukhi 3rd Generation’ in Nov 2019.
  • In Spet. 2019, Exeltis USA, Inc. had announced the Launch of Slynd™(drospirenone) tablets, the First and only progestin-only pill providing pregnancy prevention with a 24-hour missed pill window

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1091

Get Valuable Insights into Contraceptives Market

Future Market Insights, in its new report, presents an unbiased analysis of the global Contraceptives market, covering historical demand data and forecast figures for the period between 2019 and 2029. The study divulges compelling insights on the contraceptives market based on product type (contraceptive drugs – oral contraceptive pills, injectable, topical), gender (male, female), by price range (high range, low /economy), sales channel (Wholesaler/ Distributor, Hypermarket/ Supermarket, Specialty Stores, Drug & Pharma Stores, Convenience Stores, online, and others -hospitals, clinics etc.), region (North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa).

Market segmentation

Product Type

  • Contraceptive Drugs
    • Oral Contraceptive Pills
    • Injectables
    • Topical
  • Contraceptive Devices
    • Diaphgrams
    • Sponges
    • Vaginal Rings
    • Subdermal Implants
    • Intrauterine Device
    • Condom

Gender

  • Male
  • Female

Price Range

  • High Range
  • Low / Economy Range

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1091

Sales Channel

  • Wholesaler/ Distributor
  • Hypermarket/ Supermarket
  • Specialty Stores
  • Drug & Pharma Stores
  • Convenience Stores
  • Online
  • Others (hospitals, clinics etc.)

Specialty Active Pharmaceutical Ingredients Market is Booming Worldwide by 2022 | Growth, Share, Demand and Analysis Forecast To 2030

The global specialty Active Pharmaceutical Ingredients (API) market reached US$ 152.5 Bn in 2019, up by 8.5% in 2018.

Increase in the prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease has boosted the demand for specialty active pharmaceutical ingredients (API).

Manufacturers are on continuous lookout to produce new small molecule APIs. This is expected to give an impetus to the specialty active pharmaceutical ingredients (API) market during the forecast period.

Increasing investments in the specialty active pharmaceutical ingredients (API) market by key players and new technology development for low-cost production of generic drugs are the major factors expected to drive the market growth.

Key Takeaways of Specialty Active pharmaceutical ingredients (API) Market Study

  • Increasing demand in the production of generic drugs is likely to fuel demand for small molecules
  • Europe, followed by North America, is expected to be the most lucrative region and account for a notable revenue share of about 29% in the global specialty active pharmaceutical ingredients (API) market in 2020 and trend is expected to continue owing to large number of drugs going off-patent during forecast period.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1719

High patient population and growing pharmaceutical contract manufacturing organizations in Asian countries is expected to propel the growth of the specialty active pharmaceutical ingredients (API) market in the region

“Continuous focus on the development of low-cost specialty active pharmaceutical ingredients (API) and increasing incidence of infectious and metabolic diseases around the world are expected to propel the growth of the global specialty active pharmaceutical ingredients (API) market,” says an FMI Analyst.

Increasing Research Collaboration – Imperative Strategy for Market Players

Manufacturers are now focusing on discovering and developing new drug candidates through research collaborations and license agreements for the treatment of cardiovascular diseases, lung diseases and the other chronic diseases.

For instance, in March 2020, Bayer signed a research collaboration and license agreement with Indian drug discovery firm Curdev to discover novel drug candidates.

Specialty API Market Witnessing a Paradigm Shift

Shift of Specialty API Market from Type I DMFs (Drug Master Files) to Type II DMFs is expected to further drive market growth. Type II DMF drug encloses drug substances, substance materials and intermediates used in drug product’s penetration.

Extensive DMF filings are reflected through API manufacturers envisaging the steep increase in demand for outsourcing intermediates or APIs. DMF filings could also be attributed to growing investments for enhancing production facilities on the part of manufacturers based in Asia Pacific.

Also, regulatory agencies such as SAHPRA, Brazilian Health Regulatory Agency, MHRA, TGA, and U.S. FDA are in a DMF approval mode; thereby acting as another driving factor.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1719

Covid-19 to Stall Short-term Momentum

The outbreak of Covid-19 has not left any vertical untouched,  and specialty API market is no exception. Certain manufacturers are dependent on China for APIs. This influx has slowed down due to this ongoing pandemic. The trend is expected to continue at least for the next few months till manufacturers come up with an alternative to by in sync with the “new” normal.

What else is in the report?

Future Market Insights offers a unique perspective and actionable insights on specialty active pharmaceutical ingredients (API) market in its latest study, presenting historical demand assessment from 2015 – 2019 and projections from 2020–2030 based on product type (small molecules, peptides, carbohydrate drugs and steroidal drugs), by consumption (in-house and outsourced) in seven key regions.

Key Segments of Specialty Active Pharmaceutical Ingredients (API) Market

Product Type

  • Small Molecules API
    • Controlled Substances API
    • HPAPI
  • Peptides API
  • Carbohydrate Drugs API
  • Steroidal Drugs API

Consumption

  • In-house
  • Outsourced

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-1719

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Viscosupplementation Market revenues are likely to reach USD 4 billion by the end of 2030

Global viscosuppplementation revenues are likely to reach USD 4 billion by the end of 2030, according to a new research by ESOMAR-certified firm Future Market Insights.

According to the study, a number of broader, and industry-specific factors will drive growth in this market, which has been relatively less impacted by the sluggishness induced by COVID-19.

As per the UN, by 2050, those aged 60 and above will account for over 20% of the global population. In other words, the UN says that by 2050 around 130 Mn people will contract osteoarthritis. These numbers point towards growth in the viscosupplementation market in the forecast period.

Covid-19 Pandemic: Viscosuppplementation Market Players Consolidating their PositionThe ongoing Covid-19 pandemic has compelled the market players to take a consistent path for the next two quarters. As it would take some time for the healthcare vertical to look through new product launches; the players are looking at ways to smoothen the supply chain as manpower has taken a hit.

Continuous innovations are expected to propel the growth of viscosupplementation market” says the FMI analyst

viscosupplementation markekey regions and applications

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9509

Key Takeaways of Viscosupplementation Market Study   

  • Three injection viscosuppplementation is expected to contribute for more than 55% of revenue share
  • Knee osteoarthritis is expected to gain around one-third of market share during the forecast period
  • North America is the highest revenue generating market due to scientific advancements and high adoption of viscosuppplementation

New Product Development to be the TorchbearerThe market players are into the innovation mode to strengthen their foothold in the viscosupplementation market. This competitive landscape is all set to create ripples all across the market. Some of the innovations are:

  • Fidia Pharma USA Inc., in 2019, introduced a HA (Hyaluronic Acid) based intra-articular viscosupplement called “TRILURON” to treat knee osteoarthritis. The treatments cycle involves 3 injections at weekly intervals.
  • Japan-based Seikagaku Corporation, in Mar 2019, launched an intra-articular single-injection viscosupplement called “HyLink” in Italy for treating knee osteoarthritis.
  • Recently, Gel-One Hyaluronate was approved as one of the injectable gels to treat osteoarthritis of knee. The pre-market clinical study reported no pseudosepsis (severe acute inflammatory responses).

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9509

Want more insights?Viscosupplementation market, a new study from Future Market Insights, opines on the viscosupplementation from 2015 – 2019 and presents demand projections from 2020 – 2030 on the basis of; product types (single injection viscosupplementation, three injection viscosupplementation, and five injection viscosupplementation), application (knee osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, and others such as elbow and ankle joint osteoarthritis), and end user (hospitals, ambulatory surgical centers, orthopedic clinics, retail pharmacies, and online sales) across seven prominent regions.

Viscosupplementation Market: SegmentationThe global viscosupplementation market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

  • Single Injection Viscosupplementation
  • Three Injection Viscosupplementation
  • Five Injection Viscosupplementation

Application

  • Knee Oseteoarthritis
  • Hip  Oseteoarthritis
  • Shoulder Oseteoarthritis
  • Others

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Orthopedic Clinics
  • Retail Pharmacies
  • Online Sales

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/9509

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Oligonucleotide API Market to Reach US$ 4 Billion, Globally, by 2030at 11% CAGR: FMI

According to FMI – an ESOMAR-certified market research firm, the global oligonucleotide API market is estimated to reach US$ 3 Bn in 2020, and witness a CAGR of 11% through 2030.

According to FMI’s analysis, as of now, 100+ oligonucleotide APIs are in the clinical trials’ phase, and regulatory approval is on the cards. Post-approval, the demand for production capacity will witness an exponentiation, thereby driving the oligonucleotide API market through 2030.

Oligonucleotides are being looked upon as the subsequent large group of therapeutics following biologics and molecules. This could be attributed to the assurance on their part to develop drugs at lower costs.

Apart from immune therapy, microbial and cardiovascular infections, and cancer, oligonucleotide APIs are being tried out to treat neurological disorders like Alzheimer’s as well. However, factors like regulatory complexities and timely delivery of oligonucleotides (amidst Covid-19) are acting as restraints.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11933

The top 5 Key players in oligonucleotide API market include:

  • Sarepta Therapeutics,
  • Akcea Therapeutics,
  • Jazz Pharmaceuticals, Inc.,
  • Biogen,
  • Dynavax Technologies.

The players are focusing on enhancing their regional and global presence in the enterprise solutions through inorganic growth strategies. At the same time, new product launches have been on the anvil.

For instance –

  • Biogen, Inc., in May 2019, put forth interim results of phase I/II study with respect to tofersen for treating ALS (amyotrophic lateral sclerosis). Tofersen is an antisense oligonucleotide (ASO).
  • Dynavax, in the year 2017, launched Heplisav-B at the commercial level. It is a 1-month, 2-dose adult Hepatitis B vaccine.
  • In 2017, GE’s Dharmacon business partnered with CordenPharma International for creating end-to-end oligonucleotide APIs-based drugs.

Key Takeaways from Oligonucleotide API Marker Study

  • Antisense Oligonucleotides APIs are anticipated to reach US$ 4 Bn by 2030.
  • North America and Europe collectively accounted for more than 47% of revenue share in 2019 while Asia Pacific is expected to grow at the fastest rate in the forecast period.
  • Increase in use of antisense oligonucleotide APIs (especially post approval from US FDA in 2016) to boost the market in the forecast period

New Product Launches: Key Indicators to Oligonucleotide APIs Market

FMI has analyzed players such as Akcea Therapeutics, Biogen, Sarepta Therapeutics, Jazz Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., and Dynavax Technologies in this report. According to the analysis, these players are consolidating their positions through new product launches.

For instance –

  • In Mar 2020, Dynavax entered into collaboration with Clover Biopharmaceuticals for developing a vaccine candidate to combat Covid-19. Clover is into advanced evaluation of its Covid-19 S-Trimer, protein-based coronavirus vaccine candidate and Dynavax has its technical expertise along with proprietary toll-like receptor 9 (TLR9) agonist adjuvant, CpG 1018 for executing this.
  • Alnylam Pharmaceuticals, Inc., in 2018, launched Givlaari and Onpattro at the commercial level.

Gene Therapy and Oligonucleotide APIs

Synthetic oligonucleotides are being used in gene therapy for inactivating genes that help in propagating the disease. Antisense oligonucleotide APIs are used for disrupting the faulty gene’s transcription.

Also, siRNA could be used for signaling the cell to disrupt faulty mRNA’s translation. Along these lines, Pharmamar, in Jan 2020, signed an agreement with Jazz Pharmaceuticals for selling the API for “lurbinectedin”, one of the late-phase treatments for SCLC (small cell lung cancer) so that the latter could commercialize it.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-11933

Want more insights?

The study provides compelling insights on Oligonucleotide API market on basis of API type in detail cover every aspects of the market such as Antisense Oligonucleotides API, Short Interfering RNA (siRNA) API, Phosphorodiamidate Morpholino Oligonucleotides (PMO) API, MiRNA API, Aptamers API, CpG Oligonucleotides API  and Others (ON Conjugates (NP), ShRNA, etc.), Marketing Status (Marketed, Clinical Trials (Clinical Phases)), and end users (Pharmaceutical Companies  and Biotechnology Companies)) across seven major regions.

Oligonucleotide API Market: Segmentation

API Type

  • Antisense Oligonucleotides API
  • Short Interfering RNA (siRNA) API
  • Phosphorodiamidate Morpholino Oligonucleotides (PMO) API
  • MiRNA API
  • Aptamers API
  • CpG Oligonucleotides API
  • Others (ON Conjugates (NP), ShRNA, etc.)

Marketing Status

  • Marketed
  • Clinical Trials (Clinical Phases)

End User

  • Contract Manufacturing Organizations (CMOs)
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Contract Development & Manufacturing Organizations (CDMOs)

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-11933

Manual Resuscitator Market is set to surpass a valuation of USD 500 million by 2030

The global manual resuscitator market is set to surpass a valuation of USD 500 million by 2030, according to a research by ESOMAR-certified firm Future Market Insights (FMI). In a new study on the market, the

COPD (chronic obstructive pulmonary disease) is amongst the most life-threatening diseases, wherein breathlessness forms the very first symptom. The WHO states that the number of people affected by COPD crossed 250 Mn in 2019.

The US alone has more than 15 Mn cases (as per the American Lung Cancer Association). There isn’t any direct cure on records as of now. As such, symptomatic treat is being administered.

According to FMI’s analysis, manual resuscitator is sufficing at the moment. However, automation in this regard is bound to restrain the market in the years to come.

Manual Resuscitator Market Outlook and Key Findings

  • The global manual resuscitator market is expected to witness a CAGR of over 4.1% between 2020 and 2030
  • North America and Europe collectively account for more than 50% of market share and the scenario is expected to remain the same in the years to come.
  • Outbreak of Covid-19 has resulted in more than 60% of growth since Mar 2020
  • Automation of manual resuscitators is expected to restrain the market in the near future

To remain ‘ahead’ of your competitors, request for a sample

What’s with Infants and Neonates?

According to the WHO, in the year 2018, close to 2.5 Mn children died in the very first month of their life due to pre-term birth, infections, or birth asphyxia.

It further states that around 23% of infants were diagnosed with birth asphyxia in the same year. Resuscitation is a must in cases like these.

The trend mentioned above, apart from COPD, is expected to take the manual resuscitator market at a higher stride in the forecast period (2020-2030).

Key Takeaways

  • Self-inflating bags accounted for the highest market share in 2019 as the usability is greater in emergency situations. Also, NCBI states that neonatal care could be best adhered to through self-inflating bags.
  • Flow-inflating bag (better known as anaesthesia bag) is expected to witness an exponential growth between 2020 and 2030 as it finds its applications in intensive care units, wherein even a bit of fluctuation in oxygen delivery is uncalled for.
  • Out-of-hospital cardiac arrests have been increasing worldwide. Around 395,000 such cases are seen in the US alone every single year. The National Academies of Sciences, Engineering and Medicine (US) has been conducting public workshops for improving strategies to survive cardiac arrests. This will also drive the demand for manual resuscitators as the primary course of treatment.
  • The outbreak of Covid-19 has escalated the demand for manual resuscitators as breathlessness is one of the symptoms herein.

“Neonatal Care is the primary area of focus by the governments worldwide, along with heart-related ailments. This trend is bound to bolster the manual resuscitation market in the forecast period” – says the FMI analyst.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-2284

Key Participant Insights

The global market is set to enhance its scope in the forecast period, due to rising number of cardiac arrests. In addition to this, cost-effectiveness is augmenting the sales of manual resuscitator.

The key market players covered by FMI include HUM Systems for Life, GE Healthcare, Covidien Plc, Hopkins Medical Product, Drager Medical AG and Co., Laerdal Medical, Me. Ber. Srl, Hill, Ambu A/S, Philips Healthcare, CareFusion, Weinmann, and Medline Industries.

Key Segment

Type

  • flow-inflating resuscitator
  • self-inflating resuscitator
  • T-piece

Modality

  • Silicone
  • PVC
  • rubber

Technology

  • pop-off valve
  • PEEP valve
  • others

Type of Patient

  • Pediatric
  • Adult
  • Others (Neonates and Infants)

End-Use

  • hospital
  • out-of-hospital (home care, community care, primary care)
  • ASC
  • Military
  • others (specialized diagnostic centres, specialized clinics)

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2284

Geography

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • MEA